Skin Wound Healing and Scarring: Fetal Wounds and Regenerative Restitution

Birth Defects Research Part C - Embryo Today: Reviews

Volumn 96, Issue 4, 2012, Pages 325-333

  Yates, Cecelia C ^a   Hebda, Patricia ^b   Wells, Alan ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b MCGOWAN INSTITUTE FOR REGENERATIVE MEDICINE   (United States)

Author keywords

CXCR3; ECM; Fetal wounds; Fibrosis

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; FIBRONECTIN; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; PLATELET DERIVED GROWTH FACTOR; TENASCIN; THROMBOCYTE FACTOR 4; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; VASCULOTROPIN;

ACTIN FILAMENT; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; CELL THERAPY; COLLAGEN SYNTHESIS; DISEASE PREDISPOSITION; EPITHELIZATION; EXTRACELLULAR MATRIX; GENETIC PREDISPOSITION; GESTATIONAL AGE; HEMOSTASIS; HUMAN; HYDROXYLATION; HYPERTROPHIC SCAR; INNATE IMMUNITY; MUSCLE CONTRACTILITY; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; SCAR FORMATION; SKIN FIBROBLAST; SKIN INJURY; SURVIVAL; TISSUE OXYGENATION; WOUND CONTRACTION; WOUND HEALING;

CXCR3; ECM; FETAL WOUNDS; FIBROSIS;

APOPTOSIS; CELL- AND TISSUE-BASED THERAPY; CICATRIX; EXTRACELLULAR MATRIX; FETUS; FIBROBLASTS; HUMANS; PHENOTYPE; RECEPTORS, CXCR3; REGENERATION; SIGNAL TRANSDUCTION; SKIN; WOUND HEALING;

EID: 84873858154     PISSN: 1542975X     EISSN: 15429768     Source Type: Journal    
DOI: 10.1002/bdrc.21024     Document Type: Review

References (91)

1. Alaish SM, Yager DR, Diegelmann RF. 1994. Biology of fetal wound healing: hyaluronate receptor expression in fetal fibroblasts. J Pediatr Surg 29:1040.
2. Allen FD, Asnes CF, Chang P, et al. 2002. EGF induces acute matrix contraction and subsequent calpain-modulated relaxation. Wound Rep Regen 10:67-76.
3. Armstrong JR, Ferguson MW. 1995. Ontogeny of the skin and the transition from scar-free to scarring phenotype during wound healing in the pouch young of a marsupial, Monodelphis domestica. Dev Biol 169:242-260.
4. Arnout J, Hoylaerts MF, Lijnen HR. 2006. Haemostasis. Handb Exp Pharmacol 176:1-41.
5. Baneyx G, Baugh L, Vogel V. 2002. Fibronectin extension and unfolding within cell matrix fibrils controlled by cytoskeletal tension. Proc Natl Acad Sci USA 99:5139-5143.
6. Beanes SR, Dang C, Soo C, et al. 2001. Down-regulation of decorin, a transforming growth factor-beta modulator, is associated with scarless fetal wound healing. J Pediatr Surg 36:1666-1667.
7. Bodnar RJ, Yates CC, Du X, Wells A. 2009. ELR-negative chemokine IP-10/CXCL10 induces dissociation of newly-formed vessels secondary to calpain cleavage of beta3 integrin. J Cell Sci 122:2064-2077.
8. Brock J, Midwinter K, Lewis J, Martin P. 1996. Healing of incisional wounds in the embryonic chick wing bud: characterization of the actin purse-string and demonstration of a requirement for Rho activation. J Cell Biol 135:1097-1107.
9. Carter R, Jain K, Sykes V, Lanning D. 2009. Differential expression of procollagen genes between mid- and late-gestational fetal fibroblasts. J Surg Res 156:90-94.
10. Chakravarti S, Tam MF, Cheung AE. 1990. The basement membrane glycoprotein entactin promotes cell attachment and binds calcium. J Biol Chem 265:10597-10603.
11. Chen W, Fu X, Ge S, et al. 2005. Ontogeny of expression of transforming growth factor-β and its receptors and their possible relationship with scarless healing in human fetal skin. Wound Repair Regen 13:68-75.
12. Chesney J, Metz C, Stavitsky AB, et al. 1998. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. JImmunol 160:419-425.
13. Clark RA, Lin F, Greiling D, et al. 2004. Fibroblast invasive migration into fibronectin/fibrin gels requires a previously uncharacterized dermatan sulfate-CD44 proteoglycan. J Invest Dermatol 122:266-277.
14. Clark RA. 1990. Fibronectin matrix deposition and fibronectin receptor expression in healing and normal skin. J Invest Dermatol 94:128S-134S.
15. Colwell AS, Beanes SR, Soo C, et al. 2005. Increased angiogenesis and expression of vascular endothelial growth factor during scarless repair. Plast Reconstr Surg 115:204-212.
16. Coolen NA, Schouten KC, Middelkoop E, et al. 2010. Comparison between human fetal and adult skin. Arch Dermatol Res 302:47-55.
17. Demidova-Rice TN, Wolf L, Deckenback J, et al. 2012. Human platelet-rich plasma- and extracellular matrix-derived peptides promote impaired cutaneous wound healing in vivo. PLoS One 7:e32146.
18. Estes JM, Vande Berg JS, Adzick NS, et al. 1994. Phenotypic and functional features of myofibroblasts in sheep fetal wounds. Differentiation 56173-56181.
19. Gurtner GC, Werner S, Barrandon Y, Longaker MT. 2008. Wound repair and regeneration. Nature 45:314-321.
20. Harty M, Neff AW, King MW, Mescher AL. 2003. Regeneration or scarring: an immunologic perspective. Dev Dyn 226:268-279.
21. Haynes JH, Johnson DE, Mast BA, et al. 1994. Platelet-derived growth factor induces fetal wound fibrosis. J Pediatr Surg 29:1405-1408.
22. Hildebrand A, Romaris M, Rasmussen LM, et al. 1994. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J 302:527-534.
23. Hopkinson-Woolley J, Hughes D, Gordon S, Martin P. 1994. Macrophage recruitment during limb development and wound healing in the embryonic and foetal mouse. J Cell Sci 107:1159-1167.
24. Hynes RO. 2009. The extracellular matrix: not just pretty fibrils. Science 326:1216-1219.
25. Iozzo RV, Schaefer L. 2010. Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans. FEBS J 277:3864-3875.
26. Iyer AK, Tran KT, Borysenko CW, et al. 2007. Tenascin cytotactin epidermal growth factor-like repeat binds epidermal growth factor receptor with low affinity. J Cell Physiol 211:748-758.
27. Iyer AK, Tran KT, Griffith L, Wells A. 2008. Cell surface restriction of EGFR by a tenascin cytotactin-encoded EGF-like repeat is preferential for motility-related signaling. J Cell Physiol 214:504-512.
28. Kubo M, Van de Water L, Plantefaber LC, et al. 2001. Fibrinogen and fibrin are anti-adhesive for keratinocytes: a mechanism for fibrin eschar slough during wound repair. J Invest Dermatol 117:1369-1381.
29. Lane AL. 1986 Human fetal skin development. Pediatr Dermatol 3:487-491.
30. Liechty KW, Adzick NS, Crombleholme TM. 2000. Diminished interleukin 6 (IL-6) production during scarless human fetal wound repair. Cytokine 12:671-676.
31. Liechty KW, Crombleholme TM, Cass DL, et al. 1998. Diminished interleukin-8 (IL-8) production in the fetal wound healing response. J Surg Res 77:80-84.
32. Longaker MT, Chiu ES, Harrison MR. 1989 Hyaluronic acid-stimulating activity distinguishes fetal wound fluid from adult wound fluid. Ann Surg 210:667-672.
33. Longaker MT, Whitby DJ, Adzick NS, et al. 1990. Studies in fetal wound healing: second and early third trimester fetal wounds demonstrate rapid collagen deposition without scar formation. J Pediatr Surg 25:63-69.
34. Longaker MT, Whitby DJ, Ferguson MWJ, et al. 1994. Adult skin wounds in the fetal environment heal with scar formation. Ann Surg 219:65-72.
35. Lorenz HP, Lin RY, Longaker MT, et al. 1995. The fetal fibroblast: the effector cell of scarless fetal skin repair. Plast Reconstr Surg 96:1251-1259.
36. Lorenz HP, Longaker MT, Adzick NS. 1992a. Fetal wound healing. New York: Elsevier.
37. Lorenz HP, Longaker MT, Perkocha LA, et al. 1992b. Scarless wound repair: a human fetal skin model. Development 114:253-259.
38. Lucas T, Waisman A, Ranjan R, et al. 2010. Differential roles of macrophages in diverse phases of skin repair. J Immunol 184:3964-3977.
39. Martin P, Lewis J. 1992. Actin cables and epidermal movement in embryonic wound healing. Nature 360:179-183.
40. Martin P, Souza D, Martin J, et al. 2003. Wound healing in the PU.1 null mouse-tissue repair is not dependent on inflammatory cells. Curr Biol 13:1122-1128.
41. Martin P. 1997. Wound healing-aiming for perfect skin regeneration. Science 276:75-81.
42. Mast BA, Diegelmann RF, Krummel TM, et al. 1993. Hyaluronic acid modulates proliferation, collagen and protein synthesis of cultured fetal fibroblasts. Matrix 13:441-446.
43. Merkel JR, DiPaolo BR, Hallock GG, et al. 1988. Type I and Type III collagen content of healing wounds in fetal and adult rats. Proc Soc Exp Biol Med 187:493-497.
44. Merline R, Schaefer RM, Schaefer L. 2009. The matricellular functions of small leucine-rich proteoglycans (SLRPs). J Cell Commun Signal 3:323-335.
45. Nieswandt B, Varga-Szabo D, Elvers M. 2009. Integrins in platelet activation. J Thromb Haemost 1:206-209.
46. Nodder S, Martin P. 1997. Wound healing in embryos: a review. Anat Embryol 195:215-228.
47. Oshima H, Rochat A, Kedzia C, et al. 2001. Morphogenesis and renewal of hair follicles from adult multipotent stem cells. Cell 104:233-245.
48. Parekh A, Sandulache VC, Lieb AS, et al. 2007. Differential regulation of free-floating collagen gel contraction by human fetal and adult dermal fibroblasts in response to prostaglandin E2 mediated by an EP2/cAMP-dependent mechanism. Wound Repair Regen 15:390-398.
49. Peled ZM, Rhee SJ, Hsu M, et al. 2001. The ontogeny of scarless healing II: EGF and PDGF-B gene expression in fetal rat skin and fibroblasts as a function of gestational age. Ann Plast Surg 47:417-424.
50. Raab G, Klagsbrun M. 1997. Heparin-binding EGF-like growth factor. Biochim Biophys Acta 1333:F179-F199.
51. Raghow R. 1994. The role of extracellular matrix in postinflammatory wound healing and fibrosis. FASEB J 8:823-31.
52. Reed CC, Iozzo RV. 2002. The role of decorin in collagen fibrillogenesis and skin homeostasis. Glycoconjugate J 19:249-255.
53. Rendell MS, Johnson ML, Smith D, et al. 2002. Skin blood flow response in the rat model of wound healing: expression of vasoactive factors. J Surg Res 107:18-26.
54. Rendl M, Lewis L, Fuchs E. 2005. Molecular dissection of mesenchymal-epithelial interactions in the hair follicle. PLoS Biol 3:1910-1924.
55. Rhett JM, Ghatnekar GS, Palatinus JA, et al. 2008. Novel therapies for scar reduction and regenerative healing of skin wounds. Trends Biotechnol 26:173-180.
56. Rivera J, Lozano ML, Navarro-Nunez L, Vicente V. 2009. Platelet receptors and signaling in the dynamics of thrombus formation. Haematologica 94:700-711.
57. Roberts AB, Heine UI, Flanders KC, Sporn MB.1990. Transforming growth factor-beta. Major role in regulation of extracellular matrix. Ann NY Acad Sci 580:225-232.
58. Rolfe KJ, Richardson J, Vigor C, et al. 2007. A role for TGF-β1-induced cellular responses during wound healing of the non-scarring early human fetus? J Investig Dermatol 127:2656-2667.
59. Ross R, Raines EW, Bowen-Pope DF. 1986. The biology of platelet-derived growth factor. Cell 46:2:155-169.
60. Rowlatt U. 1979. Intrauterine healing in a 20-week human fetus. Virchows Arch 381:353-361.
61. Sandulache VC, Parekh A, Li-Korotky HS, et al. 2006. Prostaglandin E2 differentially modulates human fetal and adult dermal fibroblast migration and contraction: implication for wound healing. Wound Repair Regen 14:633-643.
62. Satish L, Yager D, Wells A. 2003. ELR-negative CXC chemokine IP-9 as a mediator of epidermal-dermal communication during wound repair. J Invest Dermatol 120:1110-1117.
63. Schultz GS, Davidson JM, Kirsner RS, et al. 2011.Dynamic reciprocity in the wound microenvironment. Wound Repair Regen 19:134-148.
64. Schwarzbauer JE. 1991. Alternative splicing of fibronectin: three variants, three functions. BioEssays 13:527-533.
65. Shao H, Yi XM, Wells A. 2008. Epidermal growth factor protects fibroblasts from apoptosis via PI3 kinase and rac signaling pathways. Wound Repair Regen 16:551-558.
66. Shiraha H, Gupta K, Drabik KA, Wells A. 2000. Preferential loss of epidermal growth factor receptor results in reduced responsiveness in aging dermal fibroblasts. J Biol Chem 275:19343-19351.
67. Singer AF, Clark RAF.1999. Cutaneous wound healing. N Engl J Med 341:738-746.
68. Soo C, Beanes SR, Hu FY, et al. 2003. Ontogenetic transition in fetal wound transforming growth factor-β regulation correlates with collagen organization. Am J Pathol 163:2459-2476.
69. Steffensen B, Hakkinen L, Larjava H. 2001. Proteolytic events of wound-healing-coordinated interactions among matrix metalloproteinases (MMPs), integrins, and extracellular matrix molecules. Crit Rev Oral Biol Med 12:373-398.
70. Tensen CP, Flier J, van der Raaij-Helmer EM, et al. 1999. Human IP-9. A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3). J Invest Dermatol 112:716-722.
71. Theilgaard-Monch K, Knudsen S, Follin P, Borregaard N. 2004. The transcriptional activation program of human neutrophils in skin lesions supports their important role in wound healing. J Immunol 172:7684-7693.
72. Tonnesen MG, Feng X, Clark RA. 2000. Angiogenesis in wound healing. J Investig Dermatol Symp Proc 5:40-46.
73. Tran KT, Griffith L, Wells A. 2004. Extracellular matrix signaling through growth factor receptors during wound healing. Wound Repair Regen 12:262-268.
74. Tran KT, Lamb P, Deng JS. 2005. Matrikines and matricryptins: implications for cutaneous cancers and skin repair. J Dermatol Sci 40:11-20.
75. Trebaul A, Chan EK, Midwood KS. 2007. Regulation of fibroblast migration by tenascin-C. Biochem Soc Trans 35:695-697.
76. Varga J, Rosenbloom J, Jimenez SA. 1987. Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochem J 247:597-604.
77. Velnar T, Bailey T, Smrkolj V. 2009. The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res 37:1528-1542.
78. Wagers AJ, Christensen JL, Weissman IL. 2002. Cell fate determination from stem cells. Gene Ther 9:606-612.
79. Werner S, Grose R. 2003. Regulation of wound healing by growth factors and cytokines. Physiol Rev 83:835-870.
80. Whitby DJ, Longaker MT, Harrison MR, et al. 1991. Rapid epithelialisation of fetal wounds is associated with the early deposition of tenascin. J Cell Sci 99:583-586.
81. Wierzbicka-Patynowski I, Schwarzbauer JE. 2003. The ins and outs of fibronectin matrix assembly. J Cell Sci 116:3269-3276.
82. Wilgus TA, Bergdall VK, Tober KL, et al. 2004. The impact of cyclooxygenase-2 mediated inflammation on scarless fetal wound healing. Am J Pathol 165:753-761.
83. Wulff BC, Parent AE, Meleski MA, et al. 2012 Mast cells contribute to scar formation during fetal wound healing. J Investig Dermatol 132:458-465.
84. Wynn T. 2008. Cellular and molecular mechanisms of fibrosis. J Pathol 214:199-210.
85. Yan C, Grimm WA, Garner WL, et al. 2010. Epithelial to mesenchymal transition in human skin wound healing is induced by tumor necrosis factor-alpha through bone morphogenic protein-2. Am J Pathol 176:2247-2258.
86. Yates CC, Bodnar R, Wells A. 2011. Matrix control of scarring. Cell Mol Life Sci 68:1871-1881.
87. Yates CC, Krishna P, Whaley D, et al.2010. Lack of CXC chemokine receptor 3 signaling leads to hypertrophic and hypercellular scarring. Am J Pathol 176:1743-1755.
88. Yates CC, Whaley D, Kulasekeran P, et al. 2007. Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptor. Am J Pathol 171:484-495.
89. Yates CC, Whaley D, Wells A. 2012. Transplanted fibroblasts prevents dysfunctional repair in a murine CXCR3-deficient scarring model. Cell Transplant 21:919-931.
90. Yates CC, Whaley D, Yen A, et al. 2008. ELR-negative CXC chemokine CXCL11 (IP-9/I-TAC) facilitates dermal and epidermal maturation during wound repair. Am J Pathol 173:643-652.
91. Zhang Z, Li XJ, Liu Y, et al. 2007. Recombinant human decorin inhibits cell proliferation and downregulates TGF-beta1 production in hypertrophic scar fibroblasts. Burns 33:634-641.